Crossmark

Clonal hematopoiesis of indeterminate potential is associated with increased risk of immune checkpoint inhibitor myocarditis in a prospective study of a cardio-oncology cohort

Crossref DOI link: https://doi.org/10.1186/s40959-024-00289-z

Published Online: 2024-11-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jaber Chehayeb, Rachel

Singh, Jaiveer

Matute-Martinez, Carlos

Chen, Nathan W.

Guajardo, Ana Ferrigno

Lin, Derrick

Jayakrishnan, Ritujith

Christofides, Anthos

Leveille, Etienne

Im, Yunju

Biancon, Giulia

VanOudenhove, Jennifer

Ibrahim, Eiman

Ardasheva, Anastasias

Jha, Alokkumar

Hwa, John

Halene, Stephanie

Kwan, Jennifer M.
License Information

Text and Data Mining valid from 2024-11-26

Version of Record valid from 2024-11-26
More Information

Article History

Received: 5 September 2024

Accepted: 12 November 2024

First Online: 26 November 2024

Declarations

:

: This prospective study was approved by the Yale University IRB and all participants were consented at time of enrollment.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below